Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol ED95 and side effects versus equivalent sufentanil in gastroenteroscopic anesthesia
ChiCTR1900022780Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol, sufentanil and propofol in procedural pain and anxiety disorder (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: ED95 of butorphanol and Incidence of fatigue. Started May 2019; status: recruiting.
02
Drugs
butorphanolsufentanilpropofol
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR1900022780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022780.